Skip to main content

Peer Review reports

From: The value of cystatin C in evaluating the severity and prognosis of patients with severe fever with thrombocytopenia syndrome

Original Submission
20 Nov 2021 Submitted Original manuscript
2 Jan 2022 Reviewed Reviewer Report - Akihito Sasaki
1 Feb 2022 Reviewed Reviewer Report - Baocheng Deng
8 Mar 2022 Reviewed Reviewer Report - Yong Lyu
19 Mar 2022 Author responded Author comments - Shenghua Jie
Resubmission - Version 2
19 Mar 2022 Submitted Manuscript version 2
21 Mar 2022 Author responded Author comments - Shenghua Jie
Resubmission - Version 3
21 Mar 2022 Submitted Manuscript version 3
Publishing
24 Mar 2022 Editorially accepted
9 Apr 2022 Article published 10.1186/s12879-022-07320-7

You can find further information about peer review here.

Back to article page